title: Comment on "Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study".
authors.affiliation: Interdisciplinary Department of Medicine, Rheumatology Unit, Bari, Italy. florenzo.iannone@uniba.it.
authors.forename: Florenzo
authors.initials: F
authors.lastname: Iannone
authors.affiliation: Università Cattolica del Sacro Cuore, Rome, Italy. elisa.gremese@rm.unicatt.it.
authors.forename: Elisa
authors.initials: E
authors.lastname: Gremese
authors.affiliation: Università Cattolica del Sacro Cuore, Rome, Italy. gf.ferraccioli@rm.unicatt.it.
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Ferraccioli
authors.affiliation: Interdisciplinary Department of Medicine, Rheumatology Unit, Bari, Italy. giovanni.lapadula@uniba.it.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Lapadula
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury / Q000453:epidemiology*; D000068800:Etanercept / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D008297:Male
chemical_list: D018501:Antirheumatic Agents; D000068879:Adalimumab; D000068800:Etanercept